DK0927249T3 - E2F ubiquitineringsdomæne og analyse til inhibitorer af E2F ubiquitinering - Google Patents

E2F ubiquitineringsdomæne og analyse til inhibitorer af E2F ubiquitinering

Info

Publication number: DK0927249T3
Authority: DK; Denmark
Prior art keywords: ubiquitination; domain; polypeptide; candidate; inhibitors
Prior art date: 1996-08-23

Application number

DK97936814T

Other languages

Danish (da)

English (en)

Inventor

Rene Bernards

Original Assignee

Topotarget Uk Ltd

Ver Nl Kanker Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-23

Filing date

1997-08-22

Publication date

2005-03-14

1997-08-22 Application filed by Topotarget Uk Ltd, Ver Nl Kanker Inst filed Critical Topotarget Uk Ltd

2005-03-14 Application granted granted Critical

2005-03-14 Publication of DK0927249T3 publication Critical patent/DK0927249T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
Mechanical Treatment Of Semiconductor (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK97936814T 1996-08-23 1997-08-22 E2F ubiquitineringsdomæne og analyse til inhibitorer af E2F ubiquitinering DK0927249T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9617697.9A GB9617697D0 (en)	1996-08-23	1996-08-23	Assay
PCT/GB1997/002293 WO1998007852A1 (fr)	1996-08-23	1997-08-22	Domaine d'interaction du facteur e2f avec l'ubiquitine et analyses pour l'obtention d'inhibiteurs de cette interaction

Publications (1)

Publication Number	Publication Date
DK0927249T3 true DK0927249T3 (da)	2005-03-14

Family

ID=10798859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97936814T DK0927249T3 (da)	1996-08-23	1997-08-22	E2F ubiquitineringsdomæne og analyse til inhibitorer af E2F ubiquitinering

Country Status (12)

Country	Link
US (1)	US6368809B1 (fr)
EP (1)	EP0927249B1 (fr)
JP (1)	JP2000517178A (fr)
AT (1)	ATE281520T1 (fr)
AU (1)	AU3951097A (fr)
CA (1)	CA2263803A1 (fr)
DE (1)	DE69731478T2 (fr)
DK (1)	DK0927249T3 (fr)
ES (1)	ES2232880T3 (fr)
GB (1)	GB9617697D0 (fr)
PT (1)	PT927249E (fr)
WO (1)	WO1998007852A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0963999A4 (fr) *	1996-09-30	2004-09-15	Kyowa Hakko Kogyo Kk	Composes inhibant l'activite d'e2f
CA2409717A1 (fr) *	2000-05-12	2001-11-15	Prolifix Limited	Dosage des modulateurs du cycle cellulaire basee sur la modulation de la deterioration de la cycline d1 en reponse a un rayonnement ionisant
AU2003282751A1 (en) *	2002-10-04	2004-05-04	Sloan-Kettering Institute For Cancer Research	Liposomal system and method of using same
US7052843B2 (en) *	2002-10-08	2006-05-30	New York University	Transcription-based assay for identification of post-translational modification and its application in proteomics
CN119751591B (zh) *	2025-03-06	2025-05-16	中南大学	一种靶向增稳brd7抑瘤蛋白的多肽及其在制备治疗实体肿瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6045999A (en)	1994-11-15	2000-04-04	Prolifix Limited	Transcription factor E2F-4

1996
- 1996-08-23 GB GBGB9617697.9A patent/GB9617697D0/en active Pending
1997
- 1997-08-22 US US09/242,737 patent/US6368809B1/en not_active Expired - Fee Related
- 1997-08-22 AT AT97936814T patent/ATE281520T1/de not_active IP Right Cessation
- 1997-08-22 DE DE69731478T patent/DE69731478T2/de not_active Expired - Lifetime
- 1997-08-22 ES ES97936814T patent/ES2232880T3/es not_active Expired - Lifetime
- 1997-08-22 CA CA002263803A patent/CA2263803A1/fr not_active Abandoned
- 1997-08-22 PT PT97936814T patent/PT927249E/pt unknown
- 1997-08-22 EP EP97936814A patent/EP0927249B1/fr not_active Expired - Lifetime
- 1997-08-22 DK DK97936814T patent/DK0927249T3/da active
- 1997-08-22 JP JP10510527A patent/JP2000517178A/ja not_active Ceased
- 1997-08-22 AU AU39510/97A patent/AU3951097A/en not_active Abandoned
- 1997-08-22 WO PCT/GB1997/002293 patent/WO1998007852A1/fr not_active Ceased

Also Published As

Publication number	Publication date
JP2000517178A (ja)	2000-12-26
DE69731478D1 (de)	2004-12-09
CA2263803A1 (fr)	1998-02-26
EP0927249B1 (fr)	2004-11-03
ATE281520T1 (de)	2004-11-15
DE69731478T2 (de)	2005-10-27
ES2232880T3 (es)	2005-06-01
AU3951097A (en)	1998-03-06
EP0927249A1 (fr)	1999-07-07
US6368809B1 (en)	2002-04-09
PT927249E (pt)	2005-03-31
GB9617697D0 (en)	1996-10-02
WO1998007852A1 (fr)	1998-02-26

Similar Documents

Publication	Publication Date	Title
DK0539477T3 (da)	1995-12-11	Fremgangsmåde til forstærkning af emissionssignalet af en luminescerende forbindelse
BR9710570A (pt)	2005-06-28	Inibidor de adesão de células
ATE21281T1 (de)	1986-08-15	Enzym/fluoro-immuntest fuer autoantikoerper.
NZ306051A (en)	1999-11-29	Testing using electrochemiluminescence
IS7039A (is)	2003-11-17	Raðgreiningaraðferð fyrir fjölkirni
DK0988534T3 (da)	2011-05-23	Elektroniske fremgangsmåder og apparat til detektering af analytter
AU4040097A (en)	1998-02-09	Signal amplification method
DE69521104D1 (de)	2001-07-05	Spezifische Bindungstests und Reagenzien dafür
ATE441725T1 (de)	2009-09-15	Multienzym-nachweisverfahren
DE50304023D1 (de)	2006-08-10	Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
ATE7900T1 (de)	1984-06-15	Chromogene verbindungen und ihre verwendung als enzymsubstrate.
CY1107621T1 (el)	2013-03-13	Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
DK0711415T3 (da)	1999-04-26	Immunoanalyse til påvisning af collagen eller collagenfragmenter
DK0927249T3 (da)	2005-03-14	E2F ubiquitineringsdomæne og analyse til inhibitorer af E2F ubiquitinering
NO953368L (no)	1996-03-01	Kjemiluminiserende reagens og analyse ved anvendelse av en substituert acetanilid-forbindelse for lysgenerering
DE60029413D1 (de)	2006-08-31	Enzymatische messung von mycophenolsäure
WO2000075360A3 (fr)	2001-04-19	Procede et appareil de detection d'une enzyme
DE59907982D1 (de)	2004-01-22	Verfahren zum Nachweis einer bei Apoptose aktivierten Protease
DK468582A (da)	1983-04-23	Reagens til bestemmelse af ristocetin-cofaktor (v. willebrand-faktor)
DE69632826D1 (de)	2004-08-05	Nukleinsaeure erkennung von hepatitis gb virus
DK0554314T3 (da)	1996-12-23	Fremgangsmåde til bestemmelse af Porphyromonas gingivalis
EP1103622A3 (fr)	2003-08-13	Détection d'acides nucléiques pour des espèces spécifiques utilisant un élément d'analyse
ATE350485T1 (de)	2007-01-15	Verfahren zum nachweis von acetylase oder deacetylase aktivität in einem immunoassay
PT871764E (pt)	2003-06-30	Metodo de rastreio
AU2001279695A1 (en)	2002-01-08	Methods for identifying inhibitors of the anaphase promoting complex